• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global travel vaccines market was worth US$ 4.9 Billion in 2018. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.

Global Travel Vaccines Research Report

The number of international tourist arrivals worldwide increased from 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers traveled from developed countries to regions with endemic diseases. As more people travel to countries with endemic disease, demand for vaccinations will continue to increase. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before travelling to disease-prone regions. As a result, travel vaccines have now become an important requirement in an international travelers list.  For instance, The Ministry of Health in the kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis, Poliomyelitis, etc. must present a valid vaccination certificate. Other factors driving the demand of travel vaccines include increasing awareness levels, technological advancements, increasing incidence of life-threatening infectious diseases, etc. Looking forward, we expect the global travel vaccine market to reach a value of US$ 8.1 billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.

Global Travel Vaccines Market by Region

Market Summary:

  • Based on the composition, the market has been segmented into mono vaccines and combination vaccines.
  • Based on the disease, the market has been segmented into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, japanese encepthalitis vaccines and others.
  • Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global sales.
  • The competitive landscape of the market has also been examined with some of the key players being GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, ALK-Abelló, Bavarian Nordic, Crucell N.V., CSL Limited, MedImmune, LLC, Altimmune, Abbott Laboratories and F. Hoffman-La Roche Ltd.


Key Questions Answered in This Report:

  • How has the global travel vaccines market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global travel vaccines industry?
  • What is the breakup of the global travel vaccines market on the basis of composition?
  • What is the breakup of the global travel vaccines market on the basis of disease?
  • What are the various stages in the value chain of the global travel vaccines market?
  • What are the key driving factors and challenges in the global travel vaccines market?
  • What is the structure of the global travel vaccines market and who are the key players?
  • What is the degree of competition in the global travel vaccines market?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Travel Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Composition
    5.4    Market Breakup by Disease 
    5.5    Market Breakup by Region
    5.6    Market Forecast
6    Market Breakup by Composition 
    6.1    Mono Vaccines 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Combination Vaccines 
        6.2.1    Market Trends
        6.2.2    Market Forecast
7    Market Breakup by Disease 
    7.1    Hepatitis A  
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    DPT  
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Yellow Fever
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Typhoid 
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Hepatitis B
        7.5.1    Market Trends
        7.5.2    Market Forecast
    7.6    Measles and Mumps
        7.6.1    Market Trends
        7.6.2    Market Forecast
    7.7    Rabies
        7.7.1    Market Trends
        7.7.2    Market Forecast
    7.8    Meningococcal
        7.8.1    Market Trends
        7.8.2    Market Forecast
    7.9    Varicella
        7.9.1    Market Trends
        7.9.2    Market Forecast
    7.10    Japanese Encepthalitis
        7.10.1    Market Trends
        7.10.2    Market Forecast
    7.11    Others
        7.11.1    Market Trends
        7.12.2    Market Forecast
8    Market Breakup by Region
    8.1    North America 
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Europe 
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Asia Pacific 
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Middle East and Africa
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Latin America
        8.5.1    Market Trends
        8.5.2    Market Forecast
9    Global Travel Vaccines Industry: SWOT Analysis 
    9.1    Overview 
    9.2    Strengths
    9.3    Weaknesses 
    9.4    Opportunities
    9.5    Threats
10    Global Travel Vaccines Industry: Value Chain Analysis 
    10.1    Exploratory Stage
    10.2    Preclinical and Clinical Development
    10.3    Regulatory Approval
    10.4    Manufacturing
    10.5    Marketing and Distribution
11    Global Travel Vaccines Industry: Porters Five Forces Analysis 
    11.1     Overview 
    11.2     Bargaining Power of Buyers
    11.3     Bargaining Power of Suppliers 
    11.4     Degree of Competition
    11.5     Threat of New Entrants
    11.6     Threat of Substitutes
12    Global Travel Vaccines Industry: Price Analysis 
13    Travel Vaccines Manufacturing Process

    13.1    Product Overview
    13.2    Raw Material Requirements
    13.3    Manufacturing Process
    13.4    Key Success and Risk Factors
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    GlaxoSmithKline  
        14.3.2    Sanofi Pasteur  
        14.3.3    Merck 
        14.3.4    Novartis  
        14.3.5    Pfizer   
        14.3.6    ALK-Abelló  
        14.3.7    Bavarian Nordic   
        14.3.8    Crucell N.V.  
        14.3.9    CSL Limited  
        14.3.10    MedImmune, LLC  
        14.3.11    Altimmune  
        14.3.12    Abbott Laboratories  
        14.3.13    F. Hoffman-La Roche Ltd.


List of Figures

Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion US$), 2011-2018
Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2018
Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2018
Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2018
Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
Figure 9: Global: Travel Vaccines Industry: Porter’s Five Forces Analysis
Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2011 & 2018
Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2011 & 2018
Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million US$), 2011 & 2018
Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million US$), 2011 & 2018
Figure 17: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: Travel Vaccines (Japanese Encephalitis Vaccines) Market: Sales Value (in Million US$), 2011 & 2018
Figure 19: Global: Travel Vaccines (Japanese Encephalitis Vaccines) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million US$), 2011 & 2018
Figure 21: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million US$), 2011 & 2018
Figure 23: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million US$), 2011 & 2018
Figure 25: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million US$), 2011 & 2018
Figure 27: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Global: Travel Vaccines (Others) Market: Sales Value (in Million US$), 2011 & 2018
Figure 29: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 30: North America: Travel Vaccines Market: Sales Value (in Million US$), 2011 & 2018
Figure 31: North America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 32: Europe: Travel Vaccines Market: Sales Value (in Million US$), 2011 & 2018
Figure 33: Europe: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 34: Asia Pacific: Travel Vaccines Market: Sales Value (in Million US$), 2011 & 2018
Figure 35: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 36: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million US$), 2011 & 2018
Figure 37: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 38: Latin America: Travel Vaccines Market: Sales Value (in Million US$), 2011 & 2018
Figure 39: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 40: Travel Vaccines Manufacturing: Process Flow

List of Tables

Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2019-2024
Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2019-2024
Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 5: Travel Vaccines: Raw Material Requirements
Table 6: Global: Travel Vaccines Market Structure
Table 7: Global: Travel Vaccines Market: Key Players

  

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links